Treatment of MRC-5 cells with dexamethasone, dimethyl sulfoxide, or a combination of the two enhanced the detection of herpes simplex virus by three-to fourfold in these cells. Fluorescent plaques were noticeably larger on cover slips treated with the enhancing agents. Low-positive clinical specimens were stored and tested in parallel in treated and untreated shell vials, and 6 to 40%o of these stained positive in the treated cultures but not in the untreated controls. In standard tube cultures, cytopathic effect began earlier and was more extensive in treated tubes.
With the availability of effective chemotherapeutic agents for the treatment of herpes simplex virus (HSV) infections, the need for rapid and accurate diagnosis has become more apparent. Several investigators have observed enhancement of herpesvirus replication in cell cultures treated with glucocorticoid hormones (1, (5) (6) (7) (8) , and treatment of cells with dimethyl sulfoxide (DMSO) has been reported to effect enhanced growth of human cytomegalovirus (4, 7) .
In this study, we investigated the effects of dexamethasone (DEX), DMSO, and a combination of the two agents on detection of HSV antigens in the shell vial culture test (2) as well as on HSV cytopathic effect in the standard tube culture.
The UR-3 strain of HSV-1 and the MS strain of HSV-2 were used in all experiments not involving clinical specimens. Positive clinical specimens producing less than 25% HSV-infected cells by the shell vial method were chosen, and these were stored at -70°C for 30 days and at 4°C for 0 to 3 weeks before testing. Low-multiplicity specimens sub (7) . Fluorescein-conjugated monoclonal anti-HSV-1 and anti-HSV-2 antibodies were from Syva Co., Palo Alto, Calif.
Methods for the determination of virus sensitivity in treated versus untreated cells, for cordycepin inhibition studies, and for virus growth in standard cell culture were as previously described (7) . In the time study of HSV antigen production, cultures in all treatment groups were sampled at 2-h intervals from 0 to 14 h.
When cells treated pre-and postinfection with DEX and DMSO were compared with untreated cells with regard to production of HSV-specific infectious centers, larger num-* Corresponding author.
bers of centers were consistently seen in the treated groups ( Fig. 1) . In a time study of HSV antigen production ( Fig. 2) , we found that treated cells produced more and larger plaques at each time period. Photomicrographs ( Fig. 3 ) of plaques stained after 20 h of incubation in treated and untreated cells illustrate the plaque size differences.
In clinical-specimen studies by the shell vial method, the positive rate for HSV-1 was (Table 2) .
When clinical specimens were tested in standard culture tubes, approximately twice as many cultures were positive in 24 and 48 h in treated cells as were positive in untreated cells (Tables 1 and 2 ). No growth differences appeared among the treatment groups throughout the 10-day test period.
These results suggest that the treatments may cause an increase in the susceptibility of individual cells to HSV infection or perhaps an increase in the production of virusspecific proteins within the cell, enabling visible staining to take place earlier. Inhibition studies with cordycepin, an inhibitor of mRNA (data not shown), suggest that DEXmediated enhancement is due primarily to the protein product of a cellular mRNA produced before infection (5-7). This factor may be the same as or similar to nuclear factor I, which attaches to the viral promoter region and facilitates increased transcription of the cytomegalovirus immediate early genes (3) .
In the clinical virology laboratory, the principal advantages of this treatment are the increased ease of cover slip reading, attributable to the presence of larger and more numerous plaques, and the fact that the enhanced sensitivity to infection of the treated cells results in definite increases in positive rates, especially with low-multiplicity specimens. These advantages are particularly important in high-volume laboratories, where many specimens are read daily and where transportation delays and temperature variations may cause virus titer reduction in some specimens. 
